India · Delayed Price · Currency is INR Bliss GVS Pharma Statistics
Total Valuation
BOM:506197 has a market cap or net worth of INR 17.13 billion. The enterprise value is 16.01 billion.
| Market Cap | 17.13B |
| Enterprise Value | 16.01B |
Important Dates
The next estimated earnings date is Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | Jul 24, 2025 |
Share Statistics
BOM:506197 has 105.79 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 105.79M |
| Shares Outstanding | 105.79M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | +0.71% |
| Owned by Insiders (%) | 43.94% |
| Owned by Institutions (%) | 11.40% |
| Float | 42.02M |
Valuation Ratios
The trailing PE ratio is 15.69.
| PE Ratio | 15.69 |
| Forward PE | n/a |
| PS Ratio | 1.99 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 1.52 |
| P/FCF Ratio | 26.47 |
| P/OCF Ratio | 12.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.98, with an EV/FCF ratio of 24.73.
| EV / Earnings | 14.60 |
| EV / Sales | 1.86 |
| EV / EBITDA | 12.98 |
| EV / EBIT | 17.52 |
| EV / FCF | 24.73 |
Financial Position
The company has a current ratio of 4.46, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.46 |
| Quick Ratio | 3.46 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.43 |
| Debt / FCF | 0.81 |
| Interest Coverage | 8.38 |
Financial Efficiency
Return on equity (ROE) is 10.41% and return on invested capital (ROIC) is 6.26%.
| Return on Equity (ROE) | 10.41% |
| Return on Assets (ROA) | 4.26% |
| Return on Invested Capital (ROIC) | 6.26% |
| Return on Capital Employed (ROCE) | 7.61% |
| Weighted Average Cost of Capital (WACC) | 9.53% |
| Revenue Per Employee | 8.91M |
| Profits Per Employee | 1.13M |
| Employee Count | 966 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 3.52 |
Taxes
In the past 12 months, BOM:506197 has paid 481.97 million in taxes.
| Income Tax | 481.97M |
| Effective Tax Rate | 29.46% |
Stock Price Statistics
The stock price has decreased by -7.24% in the last 52 weeks. The beta is 0.93, so BOM:506197's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -7.24% |
| 50-Day Moving Average | 163.49 |
| 200-Day Moving Average | 151.08 |
| Relative Strength Index (RSI) | 48.34 |
| Average Volume (20 Days) | 740,929 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:506197 had revenue of INR 8.60 billion and earned 1.10 billion in profits. Earnings per share was 10.32.
| Revenue | 8.60B |
| Gross Profit | 4.20B |
| Operating Income | 914.03M |
| Pretax Income | 1.64B |
| Net Income | 1.10B |
| EBITDA | 1.19B |
| EBIT | 914.03M |
| Earnings Per Share (EPS) | 10.32 |
Balance Sheet
The company has 2.01 billion in cash and 524.91 million in debt, with a net cash position of 1.48 billion or 14.00 per share.
| Cash & Cash Equivalents | 2.01B |
| Total Debt | 524.91M |
| Net Cash | 1.48B |
| Net Cash Per Share | 14.00 |
| Equity (Book Value) | 11.68B |
| Book Value Per Share | 107.21 |
| Working Capital | 6.90B |
Cash Flow
In the last 12 months, operating cash flow was 1.36 billion and capital expenditures -711.59 million, giving a free cash flow of 647.34 million.
| Operating Cash Flow | 1.36B |
| Capital Expenditures | -711.59M |
| Free Cash Flow | 647.34M |
| FCF Per Share | 6.12 |
Margins
Gross margin is 48.81%, with operating and profit margins of 10.62% and 12.74%.
| Gross Margin | 48.81% |
| Operating Margin | 10.62% |
| Pretax Margin | 19.02% |
| Profit Margin | 12.74% |
| EBITDA Margin | 13.84% |
| EBIT Margin | 10.62% |
| FCF Margin | 7.52% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.32%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.32% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 5.02% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 0.42% |
| Earnings Yield | 6.40% |
| FCF Yield | 3.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 26, 2008. It was a forward split with a ratio of 1.6.
| Last Split Date | Sep 26, 2008 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |